Xcenda

Xcenda company information, Employees & Contact Information

Explore related pages

Related company profiles:

Cencora (formerly AmerisourceBergen/Xcenda), is a strategic consultancy that enables biopharma partners to effectively communicate and deliver their brand's value to key global healthcare stakeholders, driving market access around the world. Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.cencora.com

Company Details

Employees
218
Address
1 West First Avenue, Conshohocken,pa 19428,united States
Phone
(727)771-4100
Email
in****@****nda.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
xcenda.com
HQ
Conshohocken, PA
Looking for a particular Xcenda employee's phone or email?

Xcenda Questions

News

The 340B Drug Pricing Program Needs a New Prescription - Citizens Against Government Waste

The 340B Drug Pricing Program Needs a New Prescription Citizens Against Government Waste

(PDF) Global Value Dossiers (GVDS): How to Ensure the Value Isn’t Lost in Translation - researchgate.net

(PDF) Global Value Dossiers (GVDS): How to Ensure the Value Isn’t Lost in Translation researchgate.net

Three Things to Know About the U.S. Marketplace with Biosimilars - Amgen

Three Things to Know About the U.S. Marketplace with Biosimilars Amgen

Preparing manufacturers for a changing copay landscape - Fierce Pharma

Preparing manufacturers for a changing copay landscape Fierce Pharma

Managed Care and the Impact of Glaucoma - AJMC

Managed Care and the Impact of Glaucoma AJMC

From Potential to Value: Carving a Slice of the CGT ‘PIE' - Pharmaceutical Executive

From Potential to Value: Carving a Slice of the CGT ‘PIE' Pharmaceutical Executive

Full article: Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States - Taylor & Francis Online

Full article: Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States Taylor & Francis Online

A Biosimilars Roadmap: Understanding Payer Perceptions - Pharmaceutical Executive

A Biosimilars Roadmap: Understanding Payer Perceptions Pharmaceutical Executive

Top Xcenda Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant